Voloridge Investment Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.18M | Buy |
278,920
+21,488
| +8% | +$322K | 0.02% | 799 |
|
|
2025
Q1 | $4.15M | Buy |
257,432
+141,962
| +123% | +$2.29M | 0.02% | 834 |
|
|
2024
Q4 | $2.69M | Sell |
115,470
-41,011
| -26% | -$955K | 0.01% | 903 |
|
|
2024
Q3 | $4.6M | Sell |
156,481
-118,745
| -43% | -$3.49M | 0.02% | 798 |
|
|
2024
Q2 | $6.47M | Buy |
275,226
+87,173
| +46% | +$2.05M | 0.02% | 682 |
|
|
2024
Q1 | $7.13M | Buy |
+188,053
| New | +$7.13M | 0.03% | 565 |
|